Scarica l'app Stockscreener
1.84
8.46%
-0.17
Dopo l'orario di chiusura:
1.94
0.10
+5.43%
Precedente Chiudi:
$2.01
Aprire:
$2
Volume 24 ore:
98,835
Relative Volume:
0.66
Capitalizzazione di mercato:
$9.51M
Reddito:
$755.00K
Utile/perdita netta:
$-9.33M
Rapporto P/E:
-0.3222
EPS:
-5.71
Flusso di cassa netto:
$-5.43M
1 W Prestazione:
-22.69%
1M Prestazione:
-57.31%
6M Prestazione:
-44.01%
1 anno Prestazione:
-47.78%
Intervallo 1D:
$1.78
$2.00
Intervallo di 1 settimana:
$1.78
$2.34
Portata 52W:
$1.78
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
Nome
Mangoceuticals Inc
Settore
Industria
Telefono
(833) 626-4679
Indirizzo
15110 DALLAS PKWY, SUITE 600, DALLAS
Confronta MGRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
1.84 | 9.51M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
213.68 | 34.76B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
51.24 | 9.61B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
42.58 | 7.33B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
78.80 | 6.82B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.93 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc Borsa (MGRX) Ultime notizie
MGRX stock touches 52-week low at $1.79 amid market challenges - Investing.com
Mangoceuticals issues new shares from preferred stock conversion - Investing.com India
Mangoceuticals issues new shares from preferred stock conversion By Investing.com - Investing.com South Africa
Mangoceuticals Inc (MGRX) Stock: Analyzing the Market Value - News Heater
Mangoceuticals Issues Common Stock in Exchange for Preferred - Investing.com Australia
Mangoceuticals Issues Common Stock in Exchange for Preferred By Investing.com - Investing.com South Africa
Mangoceuticals stock hits 52-week low at $2.06 - Investing.com India
Mangoceuticals stock hits 52-week low at $2.06 By Investing.com - Investing.com Australia
Mangoceuticals Inc (NASDAQ: MGRX) Stock: Bulls Should Watch This - Stocks Register
Mangoceuticals Expands into $33 Billion Addressable - GlobeNewswire
Mangoceuticals enters master distribution agreement for Diabetinol rights - TipRanks
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada - GlobeNewswire
Major Diabetes Market Breakthrough: Mangoceuticals Launches GLP-1 Alternative at Fraction of Cost - Stock Titan
Mangoceuticals Inc. (MGRX) reports earnings - Quartz
MANGOCEUTICALS, INC. SEC 10-K Report - TradingView
Mangoceuticals (NASDAQ:MGRX) Shares Up 18% – Time to Buy? - Defense World
Mangoceuticals Announces Equity and Leadership Changes By Investing.com - Investing.com Australia
Mangoceuticals, Inc. Approves Key Amendments at Special Meeting - TipRanks
Mangoceuticals Announces Equity and Leadership Changes - Investing.com
Mangoceuticals advances in H1N1 and H5N1 studies - MSN
Mangoceuticals, Inc. Now Featured on Webull Corporate Communications Service Platform - ACCESS Newswire
Shares of Healthcare Company Rise Following Product Availability Announcement - MSN
Mangoceuticals Launches PeachesRx, A Women's Telehealth Brand For Wellness And GLP-1 Treatments - Nasdaq
Mangoceuticals Announces the Launch of “PeachesRx”a - GlobeNewswire
Mangoceuticals rises on launch of women's telehealth brand - TradingView
Mangoceuticals launches PeachesRx women’s telehealth brand - TipRanks
This New Women's Health Platform Could Disrupt the $48B GLP-1 Weight Loss Market - StockTitan
Mangoceuticals Inc. issues stock for consulting services By Investing.com - Investing.com South Africa
Mangoceuticals Inc. issues stock for consulting services - Investing.com
Mangoceuticals (MGRX): A Low Float Stock on the Verge of a Short Squeeze? - Small Cap Exclusive
Mangoceuticals (NASDAQ:MGRX) versus Quipt Home Medical (NASDAQ:QIPT) Head to Head Analysis - Defense World
Mangoceuticals targets avian flu with water-based solution By Investing.com - Investing.com Nigeria
Mangoceuticals Advances Research on Avian Flu Treatment for Poultry Industry - Defense World
Mangoceuticals targets avian flu with water-based solution - MSN
Mangoceuticals, Inc. Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology - Marketscreener.com
Mangoceuticals Advances Research On Avian Flu Solution For Poultry -February 12, 2025 at 08:19 am EST - Marketscreener.com
Mangoceuticals Advances Antiviral Research on its Patented - GlobeNewswire
Revolutionary Water-Based Solution Shows Promise in Fighting Bird Flu CrisisPhase I Results Reveal Major Breakthrough - StockTitan
Mangoceuticals Inc (MGRX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Mangoceuticals (NASDAQ: MGRX): A High-Growth Play With Multiple Catalysts - Small Cap Exclusive
Mangoceuticals Expands COO Role and Increases Compensation - TipRanks
Mangoceuticals Advances H1N1 Efficacy Study Noting - GlobeNewswire
Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research - The Manila Times
Mangoceuticals advances in H1N1 and H5N1 studies By Investing.com - Investing.com UK
Major H1N1 Treatment Success: Mangoceuticals' Novel Antiviral Shows Promise Against Bird Flu - StockTitan
Mangoceuticals executes exclusive distribution agreement with Propre - TipRanks
Mangoceuticals Signs Exclusive Distribution Deal With Propre Energie For Dermytol - Nasdaq
Mangoceuticals, Inc. Executes Exclusive Distribution - GlobeNewswire
Mangoceuticals Inc Azioni (MGRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):